Howard Horn, Chief Financial Officer at Ultragenyx Pharmaceutical Inc. (RARE), sold 6,162 shares at $36.38 ($224K) on 2025-12-10, disclosed to the SEC on 2025-12-11.
Scheduled sale ($224k) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $36.38 | 3,081 | $112K | 50.0% |
| 2 | $36.38 | 3,081 | $112K | 50.0% |
| Total | $36.38 avg | 6,162 | $224K | 100% |
| Filing → |
| RARE | SELL | 2026-06-01 | $111K | — | Filing → |
| RARE | SELL | 2026-05-04 | $117K | — | Filing → |
| RARE | SELL | 2026-04-02 | $98K | — | Filing → |